Related Experiment Video
Updated: May 25, 2026
06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization
Xiaoli Chen1, Haiyan Lv1, Min Ye1
1Cancer Research Center, Medical College, Xiamen University, 422 Siming South Road, Xiamen, Fujian 361005, China.
International Journal of Pharmaceutics
|February 8, 2012
Summary
Researchers developed dual-targeting embolic nanoparticles for cancer therapy. These SP5.2/tTF-OCMCs-SPIO-NPs combine magnetic guidance and peptide targeting for enhanced tumor blood vessel embolization.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Targeted tumor therapy requires precise delivery systems.
- Superparamagnetic iron oxide nanoparticles (SPIO-NPs) offer magnetic targeting potential.
- Peptide-based targeting can enhance specificity for cancer cells.
Purpose of the Study:
- To develop novel embolic nanoparticles with dual targeting capabilities.
- To create SP5.2/tTF-OCMCs-SPIO-NPs for magnetic field-guided and peptide-directed tumor therapy.
- To improve stability and target VEGFR-1 over-expressing cells.
Main Methods:
- Surface modification of SPIO-NPs with o-carboxymethylchitosans (OCMCs) and SP5.2/tTF.
- Physicochemical characterization including morphology, size, and magnetic properties.
- Confocal microscopy, Prussian blue staining, and FX activation analysis for functional assessment.
Main Results:
- OCMCs-SPIO-NPs exhibited spherical/ellipsoidal morphology (10-20 nm) with strong magnetism.
- Demonstrated successful peptide-directed targeting, magnetic field-guided targeting, and blood coagulation activity.
- SP5.2/tTF-OCMCs-SPIO-NPs confirmed dual-targeting functionality.
Conclusions:
- Developed SP5.2/tTF-OCMCs-SPIO-NPs possess dual-targeting capabilities.
- These nanoparticles show potential for embolization therapy in tumor blood vessels.
- The dual-targeting strategy enhances precision in cancer treatment.
